Sri Sai Subramanyam Challa. EVALUATING THE EFFECTIVENESS OF RISK-BASED APPROACHES IN STREAMLINING THE REGULATORY APPROVAL PROCESS FOR NOVEL THERAPIES. J Popl Ther Clin Pharmacol. 2021;28(2):436-448. doi:10.53555/jptcp.v28i2.7421